With the price reduction of medicines, the profit margin of medicines has been further compressed, and the notion that “as long as there is a profit on product sales” has become obsolete. Today, the profit of a pharmaceutical investment enterprise cannot be obtained only on the product, but on the basis of the product's overall performance as a product of physical performance and intangible management. The production of profits is not calculated financially, but is made in the entire process of marketing management. Therefore, the budget system is not only a financial budget, but more importantly, the effective integration of business management.

In fact, pharmaceutical investment companies all want to have as many customer resources as possible. They have good ideas for the development of pharmaceutical investment. The fault is that the company does not have a good grasp of the role of old and new customers in the business investment promotion process. The company has certain advantages of loyalty and great sales potential. It is repeating the game of bears and crickets.

Pharmaceutical investment professionals believe that the marketing model is the key to the market, and a good marketing model is the key to business success. The use of integrated methods, combined with the company's own conditions, in order to choose the right marketing model, so that companies succeed. This model refers to the establishment of overseas offices in major cities nationwide after the registration of their own sales companies or pharmaceutical investment enterprise centers by pharmaceutical companies, recruiting a large number of salesmen for the development of the pharmaceutical investment market, promotion of product promotion, and later the development of a separate OTC. The marketing company specializes in the sales of pharmacies.

If your new drug station is not stable, it is necessary to find a good cause for the development of the market. If you open up the confusion, you can make the investment promotion business of the pharmaceutical company better. Domestic pharmaceutical investment companies are experiencing a "middle-aged puzzle syndrome": they are collectively fallible, collective panic, and collectively transformed. However, when we calm down and ponder over the moon, we will find that whether it is from the law of social development or Judging from the law of industrial development, the market has entered a new era.

Each pharmaceutical investment enterprise has its own fixed customers. The cooperation between these customers and enterprises ranges from three months to several years and more than ten years. The definition of the identity of the pharmaceutical investment enterprise agent is actually very simple and can be divided into two aspects: the old customer and the new customer. Old customers are companies that are collaborating or have previously cooperated, and new customers are companies that, through certain promotional methods, will be attracted to cooperate or have just cooperated. Seemingly simple, but because of its huge role in the development of the enterprise, it is necessary for pharmaceutical investment enterprises to take it seriously.